retatrutide mechanism of action retatrutide clinical trials 2024 2025 Triple Agonism Based Therapies for Obesity | Current Cardiovascular Risk Reports Retatrutide: A Triple Agonist Shaping
Description
They may also reduce thirst, meaning someone may feel the urge to drink water less than usual while on this medication
Sirirak T, Sangsupawanich P, Wongpakaran N, Srisintorn W
This was due to how food remaining in the stomach may increase the risk of aspiration while under anesthesia
Still craving junk food
Recent evidence highlights the direct and indirect anti-inflammatory properties of GLP-1, suggesting a potential additional therapeutic strategy for patients with inflammatory bowel disease (IBD)
Follow me for more evidence-based conversations that help you make informed health decisions
